A Prospective, Non-Interventional, Multinational, Observational Study With Isatuximab In Patients With Relapsed And/Or Refractory Multiple Myeloma (RRMM) Read more
A Study Of Relatlimab Plus Nivolumab In Combination With Chemotherapy Vs. Nivolumab In Combination With Chemotherapy In Participants With Stage IV Or Recurrent NSCLC Read more
A Randomized Phase 3 Study Of Sitravatinib In Combination With Nivolumab Versus Docetaxel In Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With Disease Progression On Or After Platinum-Based Chemotherapy In Combination With Checkpoint Inhibitor Therapy Read more
A Phase 2 Randomized, Double-Blind, Clinical Trial Of Trilaciclib Versus Placebo In Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) Treated With Docetaxel In The 2nd/3rd Line Setting (PRESERVE 4) Read more
Prospective Multicenter Observational Study Of Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma Starting Second- Or Third-Line Therapy And Not Receiving Autologous Stem Cell Transplant (REAL-MIND) Read more
Observational Study Of Fostamatinib As Second Line Therapy In Adult Patients With Immune Thrombocytopenia (ITP) And Insufficient Response To A Prior Therapy Read more
